This page includes the latest FDA filings for Bioverativ U S L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH | Prescription Medication | 2024-05-11 |
Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH | Prescription Medication | 2023-05-26 |
Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH | Prescription Medication | 2023-02-08 |
Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH | Prescription Medication | 2022-03-15 |
Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH | Prescription Medication | 2022-02-08 |
Bioverativ U.S. LLC. | Enjaymo | 2022-02-04 |
NCAGE Code | 7ZXA3 | BIOVERATIV U.S. LLC. |
CAGE Code | 7ZXA3 | BIOVERATIV U.S. LLC. |
S.A.M. Registration | 7ZXA3 [80521844] | BIOVERATIV U.S. LLC. |